Overview
The COVID-19 pandemic turned our world upside down. And, within the clinical trials community, nearly every aspect of research experienced unprecedented disruptions.
To help, CTTI led several efforts -- including conducting surveys, holding webinars, and developing resources -- with the goal of helping the clinical trials ecosystem adapt and move forward during the pandemic, including:
- Two playbooks of best practices: "Best Practices for Conducting Trials During the COVID-19 Pandemic" and "Best Practices for Designing High-Quality, Diverse COVID-19 Trials".
- Recordings of six CTTI COVID-19 webinars are available:
- Identifying Best Practices for Conducting Clinical Trials with FDA's COVID-19 Guidance
- Designing High-Quality, Streamlined COVID-19 Trials
- Solutions for Switching to Remote and Virtual Visits
- Engaging Racial and Ethnic Minority Patient Populations during the Pandemic
- Using Master Protocol Studies for Effective COVID-19 Treatments
- The State of U.S. COVID-19 Treatment Clinical Trials
- A daily searchable spreadsheet of the COVID-19-related studies posted on ClinicalTrials.gov is also available.
Solutions
Search AllRecommendations
Resources
Related Items
- Best Practices for Designing High-Quality, Diverse COVID-19 Trials
- Best Practices for Conducting Trials during the COVID-19 Pandemic
- The State of U.S. COVID-19 Treatment Clinical Trials
- The Fastest Path to Effective COVID-19 Treatments: Using Master Protocol Studies
- Engaging Racial and Ethnic Minority Patient Populations in COVID-19 Clinical Trials
- Adapting Clinical Trials during COVID-19: Solutions for Switching to Remote and Virtual Visits
- Identifying Best Practices for Conducting Clinical Trials with the New FDA Guidance During the COVID-19 Pandemic
News
- CTTI Updates DCT Recommendations in Response to COVID-19COVID-19 forced the clinical trials ecosystem to plan and conduct research in remote or virtual settings. In an effort to support this shift, CTTI is launching a project to update its Decentralized ...